2nd Ubiquitin Research and Drug Discovery

The field of ubiquitin research has been growing as most big pharma companies have shown interest enough to develop ubiquitin research in their pipeline. The industry has determined that there is a huge potential in the development of therapeutics. Though ubiquitin research may be considered a small community, many have seen the growth and diversity of the field to project that the field is ready toblow up in the next few years. To stay ahead of the curve, it will require you to stay on top of recent technological advancements and development trends.

GTC is proud to present our 2nd Annual Ubiquitin Research in Drug Discovery Conference! This meeting will take place on February 27-28, 2012 at the Red Rock Resort & Spa in Las Vegas, NV, and will bring together leaders from biotech and pharmaceutical companies, academia, and government, to provide you with a solid primer for a better understanding of the complex activities of ubiquitin and ubiquitin-like proteins and solutions to the challenges associated with ubiquitin drug development.

Join us for the opportunity to listen to recent updates on research, share ideas with colleagues, and network with experts from industry and academia.
Conference sessions to be discussed are:

• Targeting the Ubiquitin Proteasome Pathway

• E3 Ligases as Targets in Therapy

• Deubiquitylating Enzymes as Potential Drug Targets - Challenges and Opportunities

• Proteasome Inhibitors in the Clinic

• Future Trends and Emerging Targets

This conference is also part of the Targets and Strategies in Drug Discovery Summit which consists of three other conferences:

• 3rd Cancer Targets & Therapeutics

• Oncology Partnering and Deal-making

• 4th Ocular Diseases Drug Discovery